Syros
IPO- Business Model
- B2B
- Last Round
- Venture RoundDec 2020
- Rounds
- 4
About
Syros Pharmaceuticals is a biopharmaceutical company focused on discovering and developing gene control medicines for cancer and other diseases.
Summary
Syros is a Biotech company based in United States. Its most recent funding was a Venture Round round in Dec 2020. Investors include Polaris Partners, ARCH Venture Partners and Flagship Ventures.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Dec 2020
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company